Related Experiment Video

Updated: Jun 20, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Future aspects of immunotherapy and gene therapy in neuroblastoma

S Aktas1

  • 1Dokuz Eylul University, Institute of Oncology, Department of Basic Oncology, Izmir, Turkey. safiyeaktas@yahoo.com

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|September 29, 2009
PubMed

Insights

This review explores immuno-gene therapy for neuroblastoma (NB), a cancer with poor outcomes in high-risk patients. It discusses the translation of these advanced cancer immunotherapies into clinical trials for improved treatment strategies.

Area of Science:

  • Oncology
  • Immunology
  • Gene Therapy

Background:

  • Immunotherapy stimulates the immune system to fight cancer by targeting tumor-associated antigens (TAAs).
  • Gene therapy offers a promising strategy to reverse cancer's neoplastic phenotype or induce tumor cell self-destruction.
  • High-risk neuroblastoma (NB) and stage 4 metastatic cases over 18 months have poor prognoses despite current treatments.

Purpose of the Study:

  • To review the translation of immuno-gene therapy strategies into clinical trials for neuroblastoma (NB).
  • To discuss future directions and potential advancements in immuno-gene therapy for NB treatment.

Main Methods:

  • Literature review of existing studies on immuno-gene therapy for neuroblastoma.
  • Analysis of clinical trial data and outcomes for NB patients treated with immuno-gene therapy.

Main Results:

  • The review synthesizes current research on the application of immuno-gene therapy in neuroblastoma.
  • Identifies key challenges and successes in translating these therapies from bench to bedside.

Conclusions:

  • Immuno-gene therapy holds significant promise for improving outcomes in high-risk neuroblastoma.
  • Further research and clinical trials are essential to optimize and expand the use of immuno-gene therapy for NB.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...